Stanley McClurg, MD
Otolaryngology · Merriam, KSNPI 1659531515
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Aerin Medical Inc. accounts for 81.2% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2021 at $42,388 and has fallen 67.5% since, to $13,783 in 2025. Among otolaryngology clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 411 payments — averaging $323.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$108K
- Stryker$10K
- Intersect ENT, Inc.$7K
- Medtronic$2K
- Neurent Medical Limited$925
- Sanofi$895
- plus $4K from 27 others
What the payments were for
- Consulting fees$68,50751%
- Speaking & faculty fees$33,58125%
- Travel & lodging$6,7405%
- Food & beverage$24,31818%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 130 | $108,135 |
| Stryker | 31 | $9,719 |
| Intersect ENT, Inc. | 50 | $7,298 |
| Medtronic | 4 | $1,929 |
| Neurent Medical Limited | 8 | $925 |
| Sanofi | 42 | $895 |
| GSK | 36 | $775 |
| Optinose US, Inc. | 38 | $639 |
| Acclarent, Inc | 11 | $591 |
| KARL Storz Endoscopy-america | 10 | $511 |
| Regeneron Healthcare Solutions, Inc. | 17 | $438 |
| Integra Lifesciences Corporation | 2 | $295 |
| Olympus America Inc. | 5 | $197 |
| Next Science LLC | 1 | $160 |
| Smith+Nephew | 1 | $108 |
| Arrinex, Inc. | 1 | $64 |
| AstraZeneca | 2 | $50 |
| Merck | 3 | $45 |
| Baudax Bio Inc. | 2 | $35 |
| Davol Inc. | 1 | $32 |
| AbbVie | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Pfizer | 2 | $30 |
| Globus Medical | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Ambu Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Vertex | 1 | $24 |
| Amgen | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Bolder Surgical, LLC | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$89,795
- RHINAER STYLUS$48,288
- VivAer$10,665
- RhinAer$10,665
- ORTHOMAP$7,200
- PROPEL$3,183
- Vivaer RF Stylus$2,164
- SINUVA$2,085
- NUVENT$1,800
- ENTELLUS - XPRESS ENT DILATION SYSTEM$1,137
- NEUROMARK Radiofrequency Console$808
- NEUROMARK Device$663
- XPRESS ENT DILATION SYSTEM$567
- AERIN CONSOLE$400
- Acclarent Aera$295
- Inspira Air$295
- RELIEVA SPINPLUS NAV$295
- TruDi Probe$295
- HOPKINS II TELESCOPE 30, 4 MM X 30CM$256
- Xperience$160
How this compares
$133,147 in reported general payments places this provider in the 95th percentile of 87 otolaryngology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $44,904 |
| XhanceFluticasone Propionate | 11 | $6,457 |
| Ipratropium Bromide | 165 | $3,657 |
| Doxycycline Monohydrate | 100 | $1,373 |
| Mupirocin | 42 | $568 |
| Azelastine Hcl | 18 | $560 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 62 | $301 |
| Methylprednisolone | 38 | $268 |
| Omeprazole | 23 | $195 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $169 |
| Prednisone | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $639 | $6,45711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 87 otolaryngology providers in Kansas.
Other otolaryngology in Merriam
- Nicholas WirtzMerriam$14K
- Katherine AberleMerriam$4K
- Jason ShowmakerMerriam$2K
- Kyle KimuraMerriam$1K
- Hinrich StaeckerKansas City$499K
- Douglas CowanLeawood$32K
- Jennifer VillwockKansas City$26K
- David RudmanOverland Park$18K
- Meha FoxKansas City$12K
- Kiran KakaralaKansas City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.